BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30267783)

  • 1. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.
    Erdmann P; Bruckmueller H; Martin P; Busch D; Haenisch S; Müller J; Wiechowska-Kozlowska A; Partecke LI; Heidecke CD; Cascorbi I; Drozdzik M; Oswald S
    J Pharm Sci; 2019 Feb; 108(2):1035-1046. PubMed ID: 30267783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).
    Englund G; Jacobson A; Rorsman F; Artursson P; Kindmark A; Rönnblom A
    Inflamm Bowel Dis; 2007 Mar; 13(3):291-7. PubMed ID: 17206689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
    Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
    Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
    Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
    Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
    Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human Duodenum.
    Gravel S; Panzini B; Belanger F; Turgeon J; Michaud V
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
    Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
    Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of inflammation on the expression of drug transporters and metabolic enzymes in colonic tissue from ulcerative colitis patients.
    de Waal T; Handin N; Brouwers J; Ferrante M; Vermeire S; Vanuytsel T; Artursson P; Augustijns P
    Int J Pharm; 2022 Nov; 628():122282. PubMed ID: 36244560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional Expression Levels of Drug Transporters and Metabolizing Enzymes along the Pig and Human Intestinal Tract and Comparison with Caco-2 Cells.
    Vaessen SF; van Lipzig MM; Pieters RH; Krul CA; Wortelboer HM; van de Steeg E
    Drug Metab Dispos; 2017 Apr; 45(4):353-360. PubMed ID: 28153842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
    Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
    Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.
    Chen C; Han YH; Yang Z; Rodrigues AD
    Xenobiotica; 2011 Jun; 41(6):476-85. PubMed ID: 21381897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer resistance protein and P-glycoprotein expression in patients with newly diagnosed and therapy-refractory ulcerative colitis compared with healthy controls.
    Gutmann H; Hruz P; Zimmermann C; Straumann A; Terracciano L; Hammann F; Lehmann F; Beglinger C; Drewe J
    Digestion; 2008; 78(2-3):154-62. PubMed ID: 19052456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased sigmoidal ABCB1 (P-glycoprotein) expression in ulcerative colitis is associated with disease activity.
    Ufer M; Häsler R; Jacobs G; Haenisch S; Lächelt S; Faltraco F; Sina C; Rosenstiel P; Nikolaus S; Schreiber S; Cascorbi I
    Pharmacogenomics; 2009 Dec; 10(12):1941-53. PubMed ID: 19958093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?
    Isoherranen N; Thummel KE
    Drug Metab Dispos; 2013 Feb; 41(2):256-62. PubMed ID: 23328895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease alters intestinal bile acid transporter expression.
    Jahnel J; Fickert P; Hauer AC; Högenauer C; Avian A; Trauner M
    Drug Metab Dispos; 2014 Sep; 42(9):1423-31. PubMed ID: 24965812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.
    Szeląg-Pieniek S; Oswald S; Post M; Łapczuk-Romańska J; Droździk M; Kurzawski M
    Pharmacol Rep; 2021 Oct; 73(5):1427-1438. PubMed ID: 34117631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.